Cogent Biosciences Inc (COGT)
6.605
+0.06
(+0.99%)
USD |
NASDAQ |
Apr 18, 16:00
6.605
0.00 (0.00%)
After-Hours: 20:00
Cogent Biosciences Free Cash Flow (Quarterly): -44.38M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -44.38M |
| September 30, 2023 | -38.09M |
| June 30, 2023 | -33.32M |
| March 31, 2023 | -40.62M |
| December 31, 2022 | -31.38M |
| September 30, 2022 | -37.75M |
| June 30, 2022 | -27.60M |
| March 31, 2022 | -28.78M |
| December 31, 2021 | -21.21M |
| September 30, 2021 | -15.27M |
| June 30, 2021 | -12.63M |
| March 31, 2021 | -11.37M |
| December 31, 2020 | -9.366M |
| September 30, 2020 | -10.27M |
| Date | Value |
|---|---|
| June 30, 2020 | -8.324M |
| March 31, 2020 | -7.893M |
| December 31, 2019 | -8.458M |
| September 30, 2019 | -10.18M |
| June 30, 2019 | -11.34M |
| March 31, 2019 | -11.56M |
| December 31, 2018 | -9.02M |
| September 30, 2018 | -7.661M |
| June 30, 2018 | -8.301M |
| March 31, 2018 | -8.056M |
| December 31, 2017 | -6.616M |
| September 30, 2017 | -6.565M |
| June 30, 2017 | -5.978M |
| March 31, 2017 | -7.588M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-44.38M
Minimum
Dec 2023
-7.893M
Maximum
Mar 2020
-21.49M
Average
-15.27M
Median
Sep 2021
Free Cash Flow (Quarterly) Benchmarks
| QuidelOrtho Corp | 31.80M |
| NeuroOne Medical Technologies Corp | -3.846M |
| Agios Pharmaceuticals Inc | -72.72M |
| Tenon Medical Inc | -2.37M |
| DIH Holding US Inc | -- |